학술논문
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)
Document Type
Article
Author
Source
In Journal of the American Academy of Dermatology May 2021 84(5):1269-1277
Subject
Language
ISSN
0190-9622